UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038038
Receipt number R000043340
Scientific Title An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~
Date of disclosure of the study information 2020/03/31
Last modified on 2019/09/18 14:28:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~

Acronym

An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~

Scientific Title

An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~

Scientific Title:Acronym

An effect by abdominal position and the RTX(Clearance mode) combination for the infant intubated patients who had a diagnosis of a respiratory infectious disease and safe inspection of the patient ~Making and trial of the breathing care program~

Region

Japan


Condition

Condition

Severe pneumonia, respiratory syncytial virus infectious disease, human meta virus infectious diseases

Classification by specialty

Pneumology Pediatrics Intensive care medicine
Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It was aimed for abdominal position and the evaluation of the effect by the RTX(Clearance mode) combination and the safe inspection of the patient. And I thought that I could connect a provided result with the unification of the nursing care by making a breathing care program for the cause.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

[item evaluating abdominal position and an effect of RTX (clearance mode)]
Data during an intubation period: I change the change of X-rays, blood test data, the instructions of the respiratory condition of it and compare the difference of data before and after the enforcement using mark order official approval of Wilcoxon belonging to in analysis during an intubation period

[item evaluating safety]
Presence of harm phenomena such as a flare of the skin with the practice, edema of the face, low blood pressure, tachycardia, the symptoms such as aspirations and accident extubation, tracheal intubation tube confinement by flexure and the secretion retention of the tracheal intubation tube, a tip status pulse route, an accident withdrawal or the flexure confinement of various drains

Key secondary outcomes

[item evaluating abdominal position and an effect of RTX (clearance mode)]
1)I investigate the days that I practiced from intubation day and the day when I introduced it
2)Basic data: Age of the patient, disease name, having underlying disease or not, the weight
3)Data before and after the enforcement of the patient: Vital signs, sedation depth (SBS), change of the amount of ventilation, change of change blood gas data of SpO2, EtCO2,
4)Data during an intubation period: I change the change of X-rays, blood test data, the instructions of the respiratory condition of it and compare the difference of data before and after the enforcement using mark order official approval of Wilcoxon belonging to in 3)analysis during an intubation period

[item evaluating safety]
1)Presence of harm phenomena such as a flare of the skin with the practice, edema of the face, low blood pressure, tachycardia, the symptoms such as aspirations and accident extubation, tracheal intubation tube confinement by flexure and the secretion retention of the tracheal intubation tube, a tip status pulse route, an accident withdrawal or the flexure confinement of various drains


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

I carry out1cool RTX(clearance mode)between from 9:00 to 16:00.
While I carry it out,I make abdominal position.
1)I perform the physique conversion in medical staff(doctor,nurse,physical ther apist)more than two
2)I do 5 RTX (clearance mode) counts 1 if cool (approximately ten minutes)
Setting: 600 times of vibration /min (two minutes)
INS PRESSURE (vibration intake pressure) -10
3)I avoid (just after infusion) just after a meal to take abdominal pressure, and to have possibilities to vomit


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

15 years-old >

Gender

Male and Female

Key inclusion criteria

The tracheal intubation patient who judged that I was hospitalized with a respiratory infectious disease (severe pneumonia, respiratory syncytial virus infectious disease, human meta virus infectious diseases), and a doctor needed abdominal position and the RTX (clearance mode) combination

Key exclusion criteria

The patient that an agreement was refused

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Ippei
Middle name
Last name Watanabe

Organization

Saitama Medical Center

Division name

PICU

Zip code

350-8550

Address

Saitama, Kawagoe-shi,Kamoda, 1981,

TEL

049-228-3864

Email

smcpicu@saitama-med.ac.jp


Public contact

Name of contact person

1st name Ippei
Middle name
Last name Watanabe

Organization

Saitama Medical Center

Division name

PICU

Zip code

350-8550

Address

Saitama, Kawagoe-shi,Kamoda, 1981,

TEL

049-228-3864

Homepage URL


Email

smcpicu@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical Center

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical Center

Address

Saitama, Kawagoe-shi,Kamoda, 1981,

Tel

049-228-3864

Email

smcpicu@saitama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2019 Year 08 Month 15 Day

Date of IRB


Anticipated trial start date

2020 Year 03 Month 31 Day

Last follow-up date

2020 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 09 Month 18 Day

Last modified on

2019 Year 09 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043340


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name